Drug Profile
Katanosin B
Latest Information Update: 09 Feb 2006
Price :
$50
*
At a glance
- Originator Unknown
- Developer Shionogi; St. Marianna University School of Medicine; Toho University School of Medicine
- Class Depsipeptides
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 09 Feb 2006 No development reported - Preclinical for Bacterial infections in Japan (unspecified route)
- 15 Nov 1999 Preclinical development for Bacterial infections in Japan (Unknown route)